TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters-Reference-Cited by-同舟云学术

TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters

Published:2017-12 Issue: Volume:96 Page:371-377
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Kun,Lai Hong

Funder

Shenyang Science and Technology Bureau

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference30 articles.

1. First-line chemotherapy with or without biologic agents for metastatic breast cancer;Andreetta;Crit. Rev. Oncol. Hematol.,2010

2. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacol. Rev.,2004

3. Targeting multidrug resistance in cancer;Szakacs;Nat. Rev. Drug Discov.,2006

4. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression;Godar;Cell,2008

5. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy;Fillmore;Breast Cancer Res.,2008

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products targeting ferroptosis pathways in cancer therapy (Review);Oncology Reports;2024-07-23

2. The role of ATP‐binding cassette subfamily G member 1 in tumor progression;Cancer Medicine;2024-06

3. A comprehensive review on the use of traditional Chinese medicine for cancer treatment;Pharmacological Research - Modern Chinese Medicine;2024-06

4. The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway;Frontiers in Pharmacology;2024-05-09

5. Natural products for combating multidrug resistance in cancer;Pharmacological Research;2024-04